A new research report links asbestos exposure to kidney cancer. Today's post is shared from pubmed.com.
Copyright
(c) 2010-2024 Jon L Gelman, All Rights Reserved.
Showing posts with label Kidney Disease. Show all posts
Showing posts with label Kidney Disease. Show all posts
Saturday, June 18, 2016
Kidney Cancer Reported Related to Workers' Asbestos Exposure
Saturday, April 25, 2015
Medical Costs: Why Target the Drug Industry Now
The pharmaceutical industry may indeed be a major factor in the future success of reducing workers' compensation treatment costs and improve the success rate of care. Such action will reduce the cost of medical treatment and likewise reduce permanent disability awards.
US FDA: Designation for CRS-207 in Mesothelioma Treatment
Merck Announces Results from Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
This week several landmark announcements were made regarding the treatment of mesothelioma and Hepatitis C. The pharmaceutical industry is making great strides if treatment and cure.
Perhaps targeting the drug industry at this time merely to reduce costs is short sighted. The entire program needs to be encouraged.
US FDA: Designation for CRS-207 in Mesothelioma Treatment
Merck Announces Results from Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
Subscribe to:
Posts (Atom)